In silico drug repurposing for filarial infection predicts nilotinib and paritaprevir as potential inhibitors of the Wolbachia 5′-aminolevulinic acid synthase
Abstract Filarial infections affect millions of individuals and are responsible for some notorious disabilities. Current treatment options involve repeated mass drug administrations, which have been met with several challenges despite some successes. Administration of doxycycline, an anti-Wolbachia...
Saved in:
Main Authors: | Alexander Kwarteng, Ebenezer Asiedu, Augustina Sylverken, Amma Larbi, Yusif Mubarik, Charles Apprey |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/d02960175f9b4a74b0a1ae54fbe1f403 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New insights into the evolution of Wolbachia infections in filarial nematodes inferred from a large range of screened species.
by: Emanuele Ferri, et al.
Published: (2011) -
Spotlight on nilotinib in the treatment of chronic myelogenous leukemia
by: Harnicar S, et al.
Published: (2014) -
ACTIVITY OF AMINOLEVULINATE SYNTHASE OF BONE MARROW AND LIVER OF NEWBORN AUGUST AND WISTAR RATS AFTER ACUTE POSTNATAL HYPOXIA
by: L. I. Kolesnikova, et al.
Published: (2014) -
Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release
by: Henry J. Bailey, et al.
Published: (2020) -
Intraocular live male filarial Loa loa worm
by: André Omgbwa Eballe, et al.
Published: (2009)